Back to search
Anaplastic Large Cell Lymphoma, ALK-Negative
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anaplastic Large Cell Lymphoma, ALK-Negative trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Anaplastic Large Cell Lymphoma, ALK-Negative trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral…
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the inform…
This study involves patients with diffuse large B cell lymphoma (DLBCL), natural killer/T-cell lymphoma (NKTL), or classical Hodgkin lymphoma (cHL) (referred to…
This phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refract…
The purpose of this study is to test the safety, tolerability, efficacy, and drug levels of BMS-986369 (Golcadomide) in participants with relapsed or refractory…